SEC Form 4 · accession 0001062993-19-001150
Orgenesis Inc. · ORGS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Vered Caplan
Officer — Chief Executive Officer · Director
Period of report
Aug 22, 2014
Accepted (ET)
Mar 5, 2019 · 6:51 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001460602
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF1,F2 | $0.0001 | Aug 22, 2014 | A | 34,526 | A | — | Aug 22, 2024 | Common Stock | 34,526 | 34,526 | D |
| Stock OptionF1,F3 | $0.0001 | Aug 22, 2014 | A | 103,583 | A | — | Aug 22, 2024 | Common Stock | 103,583 | 103,583 | D |
| Stock OptionF1,F4 | $4.80 | Dec 9, 2016 | A | 166,667 | A | — | Dec 9, 2026 | Common Stock | 166,667 | 166,667 | D |
Explanation of responses
- F1Represents post-reverse stock split share amounts.
- F2These options were awarded under the Issuer's 2012 Equity Incentive Plan to purchase shares of common stock of the Issuer and vested on August 22, 2014.
- F3These options were awarded under the Issuer's 2012 Equity Incentive Plan to purchase shares of common stock of the Issuer and vested quarterly over a period of 4 years from the award date, with 77,687 of the options vesting three months following the award date.
- F4These non-plan options were awarded to purchase shares of common stock of the Issuer and vested in equal quarterly installments over a two-year period from the award date.